HARROW, INC. — Director's Dealing 2012

Apr 28, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-04-01

Reporting Person: Abrams Jeffrey J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-01	Option (Right to Buy)	$0.9	A	300000	Acquired	2022-03-31	Common Stock (300000)	Direct
2012-04-01	Option (Right to Buy)	$0.9	A	125000	Acquired	2017-03-31	Common Stock (125000)	Direct

Footnotes

F1: The stock options, granted on April 1, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Abram's options vest over a 1 year period at a strike price of $0.90, with 25,000 options vesting monthly for the next twelve month period. As of the date of this Form 3 filing, options to purchase 50,000 shares of the Issuer's common stock are exercisable, but no options have been exercised.

F2: The stock options, granted on April 1, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Abram's options maintain a strike price of $0.90, and vest quarterly over a one year term with the initial 31,250 options vesting on June 30, 2012, the next 31,250 options vesting on September 30, 2012, the next 31,250 options vesting on December 31, 2012 and the final 31,250 options vesting on March 31, 2013.